## Protocol Section
### Identification Module
**NCT ID:** NCT06421792

**Acronym:** POISON

**Brief Title:** PrOtamIne doSing clOt imagiNg (POISON) Study

**Official Title:** Scanning Electron Microscopy (SEM) and Confocal Imaging of Clot in Two Different Protamine Environments (PrOtamIne doSing clOt imagiNg (POISON) Study)

#### Organization Study ID Info
**ID:** T03024
#### Organization
**Class:** OTHER_GOV
**Full Name:** Papworth Hospital NHS Foundation Trust
### Status Module
#### Completion Date
**Date:** 2024-12-31

**Type:** ESTIMATED

#### Expanded Access Info
#### Last Update Post Date
**Date:** 2024-05-20

**Type:** ACTUAL

**Last Update Submit Date:** 2024-05-14

**Overall Status:** NOT_YET_RECRUITING

#### Primary Completion Date
**Date:** 2024-12-31

**Type:** ESTIMATED

#### Start Date
**Date:** 2024-05-08

**Type:** ESTIMATED

**Status Verified Date:** 2024-05

#### Study First Post Date
**Date:** 2024-05-20
**Type:** ACTUAL
**Study First Submit Date:** 2024-04-21
**Study First Submit QC Date:** 2024-05-14
### Sponsor Collaborators Module

#### Collaborators

**Class:** OTHER

**Name:** University of Oxford

**Class:** OTHER

**Name:** University of Liverpool

**Class:** OTHER_GOV

**Name:** Medical Research Council

#### Lead Sponsor

**Class:** OTHER_GOV

**Name:** Papworth Hospital NHS Foundation Trust

#### Responsible Party

**Type:** SPONSOR

### Oversight Module

**Is FDA Regulated Device:** False

**Is FDA Regulated Drug:** False

**Oversight Has DMC:** False

### Description Module

**Brief Summary:** The proposed study involves using two different high-resolution microscopic imaging techniques to examine the health and platelet invasion of clot in patients who were given 1:1 protamine / heparin and compare this to clot from patients who had heparin reversed using the PRODOSE algorithm. Patients will be treated according to the routine clinical practice of their individual care team.

**Detailed Description:** Sample collection at RPH

Patients will have a total of 14ml of blood taken during the procedure.

The first 7ml will be taken after induction of anaesthesia along with routine blood gas and coagulation sampling through the routinely indwelling arterial catheter. The initial sample must be taken before any heparin has been administered. This will be used to fill 2 x 3.5ml citrated (green top) blood tubes. These will be clearly labelled as "pre-heparin" with a Tissue Bank ID number.

The second 7ml will be taken 5 minutes after heparin has been reversed with protamine after cessation of cardiopulmonary bypass. It will again be taken at the same time as routine sampling for blood gas and coagulation studies. Analog to the first sample, it will again be divided and used to fill 2 x 3.5ml citrated (green top) blood tubes. These will be clearly labelled as "post-protamine" with the same ID number and whether "1:1" or a "PRODOSE algorithm determined" protamine: heparin ratio was used.

In keeping with clinical routine, ROTEM coagulation testing and full blood counts will be requested as seen necessary by the clinical team.

The samples will be sent to Royal Papworth Hospital (RPH) Tissue Bank for initial processing. Samples need to be processed within 4 hours of blood draw.

After initial processing, samples will be sent for confocal imaging to the MRC Laboratory of Molecular Biology (LMB) and for SEM imaging to the University of Oxford respectively.

Clinical data to be collected (to be completed by anaesthetic team).

1. Demographic information: Age / Gender / Weight / Height / Medication history;
2. Type of surgery;
3. Cardiac drug history and antiplatelets / anticoagulants and timing;
4. Coagulation tests (ACT / ROTEM) at the following points: a) Pre-heparin, b) Post-heparin, pre-CPB, c) Throughout CPB, c) Post-protamine;
5. Full blood count at the following points: a) Pre-surgery and date of sample, b) Post-protamine; 6) CPB and x-clamp times, nadir temperature

### Conditions Module

**Conditions:**

- Cardiac Surgery

### Design Module

#### Design Info

**Observational Model:** OTHER

**Time Perspective:** OTHER

#### Enrollment Info

**Count:** 20

**Type:** ESTIMATED

**Study Type:** OBSERVATIONAL

### Arms Interventions Module

#### Arm Group 1

**Description:** 10 patients receiving standard reversal with 1:1 protamine / heparin ratio

**Label:** Standard

#### Arm Group 2

**Description:** 10 patients who had heparin reversed using the PRODOSE algorithm anticipated (average protamine / heparin ratio 0.6:1).

**Label:** PRODOSE Algorithm

### Outcomes Module

#### Primary Outcomes

**Description:** The proposed study involves using two different high-resolution microscopic imaging techniques to examine the health and platelet invasion of clot in patients who were given 1:1 protamine / heparin and compare this to clot from patients who had heparin reversed using the PRODOSE algorithm.

This is an observational study in which differences between images of clot obtained from samples from the two patient groups and before and after cardiopulmonary bypass will be described.

**Measure:** High-resolution microscopic images (Scanning Electron Microscopy and Confocal Imaging)

**Time Frame:** Pre Heparin and Post Protamine [5 minutes after heparin has been reversed]

### Eligibility Module

**Eligibility Criteria:** Inclusion Criteria:

* undergoing elective, uncomplicated single procedure cardiac surgery with anticipated CPB duration \< 120 min
* with all anticoagulant drugs stopped at least 5 days before surgery, apart from aspirin
* with normal full blood count and clotting screen pre-OP.

Exclusion Criteria:

* emergency surgery
* inability to stop anticoagulants except aspirin for 5 days pre-OP
* complex surgery with anticipated CPB duration \> 120min
* operations planned to be done at temperature on CPB \< 34 degrees
* operations requiring deep hypothermic circulatory arrest, solid organ transplantation
* know blood dyscrasia
* intra-operative blood or blood product transfusion or post-operative coagulopathy

**Sampling Method:** NON_PROBABILITY_SAMPLE

**Sex:** ALL

**Standard Ages:**

- CHILD

- ADULT

- OLDER_ADULT

**Study Population:** Patients undergoing elective, uncomplicated single procedure cardiac surgery with anticipated CPB duration \< 120 min

### Contacts Locations Module

#### Locations

**Location 1:**

**City:** Cambridge

**Country:** United Kingdom

**Facility:** Royal Papworth Hospital NHS Foundation Trust

**State:** Cambridgeshire

**Zip:** CB23 3RE

### IPD Sharing Statement Module

**Description:** Small observational study so IPD not relevant

**IPD Sharing:** NO

### References Module

#### References

**Citation:** Miles LF, Burt C, Arrowsmith J, McKie MA, Villar SS, Govender P, Shaylor R, Tan Z, De Silva R, Falter F. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial. PLoS Med. 2021 Jun 7;18(6):e1003658. doi: 10.1371/journal.pmed.1003658. eCollection 2021 Jun.

**PMID:** 34097705

## Derived Section

### Intervention Browse Module - Browse Branches

- Abbrev: FiAg

- Name: Fibrinolytic Agents

- Abbrev: AnCoag

- Name: Anticoagulants

- Abbrev: All

- Name: All Drugs and Chemicals

- Abbrev: Coag

- Name: Coagulants

### Intervention Browse Module - Browse Leaves

- ID: M9579

- Name: Heparin

- Relevance: LOW

- As Found: Unknown

- ID: M46053

- Name: Calcium heparin

- Relevance: LOW

- As Found: Unknown

- ID: M14342

- Name: Protamines

- Relevance: LOW

- As Found: Unknown

### Misc Info Module

- Version Holder: 2024-05-31
